News/ Sales and Marketing/ US Roche keeps Rituxan evergreen with Breakthrough designation, new formulation Andrew McConaghie biosimilars, rituximab, Roche 0 Comment Roche is finding new ways to keep its oncology and rheumatoid arthritis blockbuster Rituximab/MabThera (rituximab) a big seller, Share X Roche keeps Rituxan evergreen with Breakthrough designation, new formulation https://pharmaphorum.com/news/roche-keeps-rituxan-evergreen-breakthrough-designation-new-formulation/
